The acute phase protein YKL-40 is a novel potential biomarker of inflammation in patients with coronary heart disease, and macrophages in atherosclerotic plaques express YKL-40, with the highest expression seen in macrophages with early atherosclerotic lesions. Here, CHI3L1 is linked to coronary artery disorder.